Eiger BioPharmaceuticals, Inc. Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Eiger BioPharmaceuticals, Inc. annual/quarterly Cost of Revenue history and growth rate from 2020 to 2023.
  • Eiger BioPharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $115K, a 90.7% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2023 was $24K, a 98.7% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2022 was $1.84M, a 147% increase from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2021 was $745K.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24K -$1.81M -98.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 $1.84M +$1.09M +147% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $745K +$745K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.